REGENERON PHARMACEUTICALS (REGN) Stock Cash Flow
NASDAQ:REGN - Nasdaq - US75886F1075 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 4.65B | 3.95B | 4.34B | 8.08B | 3.51B | |||
| Depreciation Amortization | 469.50M | 421.00M | 341.40M | 286.20M | 235.90M | |||
| Income Taxes - Deferred | -763.40M | -837.80M | -746.40M | -147.10M | 75.60M | |||
| Change In Working Capital | -593.30M | -94.10M | -243.30M | -1.92B | -1.50B | |||
| Interest Paid | N/A | 73.10M | 53.70M | 55.80M | 23.20M | |||
| Taxes Paid | N/A | 870.30M | 1.50B | 1.22B | 188.10M | |||
| Other non cash items | 480.10M | 1.15B | 1.32B | 783.40M | 297.00M | |||
| OPERATING CASH FLOW | 4.25B | 4.59B | 5.01B | 7.08B | 2.62B | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -928.10M | -926.40M | -1.62B | -551.90M | -614.60M | |||
| Other Investing Activity | -1.96B | -2.26B | -2.17B | -4.83B | 544.00M | |||
| INVESTING CASH FLOW | -2.88B | -3.19B | -3.78B | -5.38B | -70.60M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | 0.00 | 1.98B | |||
| Stock Issued/Repurchased | -243.90M | -1.09B | -563.30M | 26.90M | -3.27B | |||
| Other Financing Activity | -1.27B | -700.60M | -445.70M | -1.03B | -680.80M | |||
| FINANCING CASH FLOW | -1.51B | -1.79B | -1.01B | -1.01B | -1.97B | |||
| Exchange Rate Effect | 200.00K | -400.00K | N/A | N/A | N/A | |||
| CHANGE IN CASH | -148.40M | -381.60M | 221.30M | 690.80M | 577.00M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 4.25B | 4.59B | 5.01B | 7.08B | 2.62B | |||
| Capital Expenditure | -928.10M | -926.40M | -1.62B | -551.90M | -614.60M | |||
| FREE CASH FLOW | 3.32B | 3.67B | 3.40B | 6.53B | 2.00B | |||
All data in USD